Literature DB >> 17005708

Alternate polypurine tracts affect rous sarcoma virus integration in vivo.

Jangsuk Oh1, Kevin W Chang, W Gregory Alvord, Stephen H Hughes.   

Abstract

When the endogenous polypurine tract (PPT) of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z was replaced with alternate retroviral PPTs, the fraction of unintegrated viral DNA with the normal consensus ends significantly decreased and the retention of part of the PPT significantly increased. If the terminus of the U3 long terminal repeat (LTR) is aberrant, RSV integrase can correctly process and integrate the normal U5 LTR into the host genome. However, the canonical CA is not involved in joining the aberrant U3 LTR to the host DNA, generating either large duplications or deletions of the host sequences instead of the normal 5- or 6-bp duplication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005708      PMCID: PMC1617299          DOI: 10.1128/JVI.00361-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  11 in total

1.  Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract.

Authors:  M D Powell; J G Levin
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Authors:  Jangsuk Oh; John G Julias; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H.

Authors:  A J Rattray; J J Champoux
Journal:  J Mol Biol       Date:  1989-08-05       Impact factor: 5.469

5.  Selection of optimal polypurine tract region sequences during Moloney murine leukemia virus replication.

Authors:  N D Robson; A Telesnitsky
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Effects of 3' untranslated region mutations on plus-strand priming during moloney murine leukemia virus replication.

Authors:  N D Robson; A Telesnitsky
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.

Authors:  Chandravanu Dash; Jason W Rausch; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

View more
  11 in total

1.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 2.  Retroviral integrase proteins and HIV-1 DNA integration.

Authors:  Lavanya Krishnan; Alan Engelman
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

3.  Retroviral Integrase Structure and DNA Recombination Mechanism.

Authors:  Alan Engelman; Peter Cherepanov
Journal:  Microbiol Spectr       Date:  2014

4.  Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease.

Authors:  Alice Rusmevichientong; Samson A Chow
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

5.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

6.  Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.

Authors:  Sanggu Kim; Alice Rusmevichientong; Beihua Dong; Roland Remenyi; Robert H Silverman; Samson A Chow
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

Review 7.  Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.

Authors:  Steven J Smith; Xue Zhi Zhao; Dario Oliveira Passos; Dmitry Lyumkis; Terrence R Burke; Stephen H Hughes
Journal:  Viruses       Date:  2021-01-29       Impact factor: 5.048

8.  Viral reverse transcriptases show selective high affinity binding to DNA-DNA primer-templates that resemble the polypurine tract.

Authors:  Gauri R Nair; Chandravanu Dash; Stuart F J Le Grice; Jeffrey J DeStefano
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

9.  Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas.

Authors:  James F Justice; Robin W Morgan; Karen L Beemon
Journal:  MBio       Date:  2015-12-15       Impact factor: 7.867

10.  Drug resistant integrase mutants cause aberrant HIV integrations.

Authors:  Janani Varadarajan; Mary Jane McWilliams; Bryan T Mott; Craig J Thomas; Steven J Smith; Stephen H Hughes
Journal:  Retrovirology       Date:  2016-09-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.